Obesity, Metabolic Syndrome & Fatty Liver Disease:
New Standards in Diagnosis and Management

Saturday, June 18, 2016 @ 12:30 PM – 6:00 PM

The Westin Austin At The Domain, 11301 Domain Drive, Austin, TX 78758

The symposium will follow a highly interactive case based format. A moderator will present a patient scenario that attendees would likely see in their practices. Through a series of questions, the panel will define possible diagnoses and will present relevant information on that disease state.

Welcome/Overview of accredited program


Interactive Case Presentation: Session 1

  • Patient overview (Sharon Liu, DO)
  • Cardiovascular disease management (Paul Dlabal, MD)
  • Patterns of lipid abnormalities: Are all lipids bad? (Paul Dlabal, MD)
  • Type 2 diabetes management (Nicolas Musi, MD)
  • HCV: Is metabolic syndrome still a negative predictive factor? (Eric Lawitz, MD)
  • Obesity management (Nicole Basa, MD)
  • Panel discussion/Q&A
Slides #1
Slides #2

Interactive Case Presentation: Session 2 (Fast forward 10 years)

  • Patient overview (Jennifer Wells, MD)
  • NASH: Workup and diagnosis (Fred Poordad, MD)
  • NASH: Prognosis and management (Carmen Landaverde, MD)
  • Gut microbiome, diet and probiotics: Role in endocrine and liver diseases (Nicolas Musi, MD)
  • Cancer surveillance: Hepatocellular carcinoma and other cancers (20 min) (Jennifer Wells, MD)
  • Panel discussion/Q&A